Search research articles
Contact Us
Filters
Showing results (281-290 of 319) with videos related to
Page
of 32
Sort By:
The Journal of Urology
|
March 23, 2023
Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer
Adam C Schneider, Thenappan Chandrasekar, Nicholas Bowler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
Susan Halabi, Akash Roy, Larysa Rydzewska, et al.
JCO Precision Oncology
|
February 14, 2024
Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
Philip J Saylor, Keisuke Otani, Rene Balza, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
Associations between Exposure to Perfluoroalkyl Substances with Subsequent Body Composition and Glycemic Responses to Bariatric Surgery
Saketh Sankara, Matthew R Smith, Stephanie M Eick, et al.
The Lancet. Oncology
|
February 8, 2022
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Matthew R Smith, Howard I Scher, Shahneen Sandhu, et al.
Cancer Discovery
|
October 25, 2012
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer
David T Miyamoto, Richard J Lee, Shannon L Stott, et al.
The New England Journal of Medicine
|
February 9, 2018
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Matthew R Smith, Fred Saad, Simon Chowdhury, et al.
European Urology Oncology
|
May 6, 2025
Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial
Kim N Chi, Elena Castro, Gert Attard, et al.
Cancer Medicine
|
November 11, 2024
Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis
Motohide Uemura, Hiroaki Kikukawa, Yasuhiro Hashimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2024
Reply to J.A. Garcia et al
Susan Halabi, Siyuan Guo, Akash Roy, et al.
Page
of 32
Search research articles
Search
Showing results (281-290 of 319) with videos related to
Sort By:
Page
of 32
The Journal of Urology
|
March 23, 2023
Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer
Adam C Schneider, Thenappan Chandrasekar, Nicholas Bowler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
Susan Halabi, Akash Roy, Larysa Rydzewska, et al.
JCO Precision Oncology
|
February 14, 2024
Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
Philip J Saylor, Keisuke Otani, Rene Balza, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
Associations between Exposure to Perfluoroalkyl Substances with Subsequent Body Composition and Glycemic Responses to Bariatric Surgery
Saketh Sankara, Matthew R Smith, Stephanie M Eick, et al.
The Lancet. Oncology
|
February 8, 2022
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Matthew R Smith, Howard I Scher, Shahneen Sandhu, et al.
Cancer Discovery
|
October 25, 2012
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer
David T Miyamoto, Richard J Lee, Shannon L Stott, et al.
The New England Journal of Medicine
|
February 9, 2018
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Matthew R Smith, Fred Saad, Simon Chowdhury, et al.
European Urology Oncology
|
May 6, 2025
Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial
Kim N Chi, Elena Castro, Gert Attard, et al.
Cancer Medicine
|
November 11, 2024
Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis
Motohide Uemura, Hiroaki Kikukawa, Yasuhiro Hashimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2024
Reply to J.A. Garcia et al
Susan Halabi, Siyuan Guo, Akash Roy, et al.
Page
of 32